What to Expect?
____________________________________________________________________________________
More specifically, these presentations will address:
- Solving the Financial Gap Facing Patients to Reduce Dropouts and Costly Delays
- Leveraging Software Solutions to Address Industry Challenges in Compliance, Operations and Regulation Harmonization
- Using AI Analytics to Reduce Cost/Timelines in Drug Development
- Optimizing Biosample Collection and Analysis to Fulfill the Promise of Global DCTs
- Transformative Innovation in the Site Contract Life Cycle
- Using Data to Enhance Precision Recruitment and Accelerate Your Clinical Trial
____________________________________________________________________________________
Solving the Financial Gap Facing Patients to Reduce Dropouts and Costly Delays
This session will:
Review the economic burdens that prevent patients of lower income statuses from participating and remaining in clinical trials
Provide the business case for implementing reimbursement tools that solve for dropouts due to financial challenges, and ultimately how that benefits the study
Specify how Mural Health is addressing financial challenges for patients and helping sponsors
Speaker:
Sam Whitaker
Co-Founder & CEO, Mural Health
____________________________________________________________________________________
Leveraging Software Solutions to Address Industry Challenges in Compliance, Operations and Regulation Harmonization
This session will address:
How software can be better measuring, tracking and reporting on operations, safety and quality, and consolidating information across disparate systems
Ensuring ethics, compliance and innovation are present and meaningfully applied to clinical partnerships
Strategies for integrating cutting-edge technology and implementing change within your organization
Speaker:
Jeremiah Rehm
Sr. Product Manager, Sitero
_______________________________________________________________________________
Using AI Analytics to Reduce Cost/Timelines in Drug Development
This session will address:
The challenges that many pharmaceutical and biotechnology companies face:
How AI analytics can be applied to mitigate increasing costs and timelines of drug development
Transforming data to find insights within clusters of relevant data for drug developers
Practical case example of a purpose-built data network platform, to incorporate multi-modal healthcare data into a scalable, global network
Speaker:
Enrique Garcia-Rivera, PhD
VP Artificial Intelligence, BullfrogAI
_____________________________________________________________________________________
Optimizing Biosample Collection and Analysis to Fulfill the Promise of Global DCTs
This session will address:
Simplifying technology selection to help sponsors collect high-quality, self-service biosamples across the globe
How to reduce costs, eliminate attrition and radically accelerate time to endpoint through an out-of-the-box-experience (OOBE) and digital symptom diaries
Bento’s approach to transform study participation into an immersive, user-friendly experience
Speakers:
Kelly M. McVearry, PhD, MA, EdM
CEO, Bento Biology Platforms
Board Chair Emerita, Lupus Therapeutics,
a subsidiary of the Lupus Research Alliance
Kenneth Kalunian, MD
Co-founder, Bento Biology Platforms
Professor of Medicine, University of California, San Diego School
of Medicine, Division of Rheumatology, Allergy and Immunology Director, Lupus Center of Excellence
_____________________________________________________________________________________
Transformative Innovation in the Site Contract Life Cycle
This session will address:
Methods to eliminate the “pain” of manual processes of site contracts and payments, which are routinely listed as top reasons for study delay
An intelligent, data-driven architecture for data sharing, transparency across the CTA lifecycle, and automating workflows
Strategies for transforming the end-to-end process for full integration of the technology solution
Speaker:
Kevin Williams, MBA, MS
Head, Clinical Solutions, Ledger Run
________________________________________________________________________________
Using Data to Enhance Precision Recruitment and Accelerate Your Clinical Trial
This session will address:
Evidation’s approach to precision recruitment by leveraging self-reported longitudinal data, passive digital data and AI to enrich study population, and broadening early funnel
Segmentation and targeting of patient populations, and measuring individuals’ health risk using person-provided ePROs, surveys, and continuous objective data
Two case study examples showcasing the power of precision recruitment
Speaker:
Abby Levine, PhD
Senior Director, Consumer, Evidation
